Genetics and Anxiety
All the data for a heritable anxious component.
Posted June 30, 2020
A few months ago, we did a review of the latest in psychiatric genetics. We know that most psychiatric disorders have a strong heritable component, up to 75% for ADHD or schizophrenia, and 25-40% for anxiety, PTSD, and OCD. But it is definitely not as simple as a single gene predisposing you for anxiety. No, it’s a complex interaction of probably thousands of genes and their interplay with environment that can lead to clinical anxiety that affects function.
In a new study using data from the Million Veteran Program, scientists were able to study the links between anxiety and genes in a huge database, with some interesting findings.
Anxiety disorders are among the most common psychiatric disorders, affecting 1 in 10 people yearly. While anxiety can be adaptive (it certainly helps to have a level of anxiety to make sure you are paying your rent every month), they can also severely inhibit normal functioning to the point that people can’t work or even leave their homes. Clinical anxiety means the fear and other symptoms are out of proportion to the actual events and result in significant distress and disability.
When you look at the genomes of a large number of individuals and correlate common genes with clinical anxiety, there are a few major findings. Novel genetic variants were discovered around several genes related to the hypothalamic-pituitary-adrenal axis, neuronal development, and the regulation of gene expression. There is a large overlap between symptoms of PTSD, generalized anxiety, and OCD, and there seems to be a large genetic risk overlap as well. This is not surprising and can also explain why similar treatments, such as SSRIs and psychotherapy, can be effective for all kinds of anxiety.
The hypothalamic-pituitary-adrenal axis genetic differences are no surprise. This is the hormonal system that regulates the fight or flight vs. the rest and digest sympathetic and parasympathetic nervous systems. There is a lot of evidence to suggest that overreaction of the sympathetic nervous system (fight or flight) without sufficient reaction from the parasympathetic nervous system (rest and digest) is a major cause of clinical anxiety and other psychiatric disorders. Variations in the genes regulating these systems could explain a susceptibility to anxiety disorders under stressful conditions. Most treatment programs for anxiety involve strengthening the parasympathetic nervous system via mediation, stress regulation, and (probably more important) appropriate sleep regulation and self-care. It’s no surprise that genetic differences in the HPA axis could result in a greater susceptibility to clinical anxiety disorders.
One interesting finding of this genetic trawling compared to anxiety symptoms was a link to an estrogen receptor, ESR1. In mice, administration of estrogen has shown increased anxiety behaviors, and there are definitely sex-related differences in the diagnosis of anxiety and PTSD. Women are more than twice as likely to get anxiety disorders as men. It’s possible that genetic variations around estrogen receptors might explain some of this difference, or we may need to look towards testosterone and aggression.
We are very early in our understanding of the heritability of psychiatric disorders. It’s hopeful that more information could decrease stigma and give clues to novel treatments in addition to the helpful psychodynamic, cognitive behavioral therapy, and other directed treatments for anxiety that we already have. Linking pathophysiology to psychopathology will help all of us in the future treating anxiety disorders.
Copyright Emily Deans MD